These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 25862836)

  • 21. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
    Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.
    Mariño-Enríquez A; Hornick JL; Dal Cin P; Cibas ES; Qian X
    Cancer Cytopathol; 2014 Feb; 122(2):128-37. PubMed ID: 24227706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma.
    Przybyl J; Spans L; Ganjoo K; Bui N; Mohler D; Norton J; Poultsides G; Debiec-Rychter M; van de Rijn M
    PLoS One; 2022; 17(1):e0262272. PubMed ID: 34986184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas.
    Hostein I; Pelmus M; Aurias A; Pedeutour F; Mathoulin-Pélissier S; Coindre JM
    J Pathol; 2004 Jan; 202(1):95-102. PubMed ID: 14694526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.
    Kashima T; Halai D; Ye H; Hing SN; Delaney D; Pollock R; O'Donnell P; Tirabosco R; Flanagan AM
    Mod Pathol; 2012 Oct; 25(10):1384-96. PubMed ID: 22699518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
    Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
    Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma.
    Creytens D; van Gorp J; Savola S; Ferdinande L; Mentzel T; Libbrecht L
    Virchows Arch; 2014 Jul; 465(1):97-108. PubMed ID: 24659226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the preadipocyte marker ZFP423 is dysregulated between well-differentiated and dedifferentiated liposarcoma.
    Dang TN; Tiongco RP; Brown LM; Taylor JL; Lyons JM; Lau FH; Floyd ZE
    BMC Cancer; 2022 Mar; 22(1):300. PubMed ID: 35313831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
    Wang X; Asmann YW; Erickson-Johnson MR; Oliveira JL; Zhang H; Moura RD; Lazar AJ; Lev D; Bill K; Lloyd RV; Yaszemski MJ; Maran A; Oliveira AM
    Genes Chromosomes Cancer; 2011 Nov; 50(11):849-58. PubMed ID: 21793095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.
    Saâda-Bouzid E; Burel-Vandenbos F; Ranchère-Vince D; Birtwisle-Peyrottes I; Chetaille B; Bouvier C; Château MC; Peoc'h M; Battistella M; Bazin A; Gal J; Michiels JF; Coindre JM; Pedeutour F; Bianchini L
    Mod Pathol; 2015 Nov; 28(11):1404-14. PubMed ID: 26336885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.
    Lee SE; Kim YJ; Kwon MJ; Choi DI; Lee J; Cho J; Seo SW; Kim SJ; Shin YK; Choi YL
    Histol Histopathol; 2014 Jan; 29(1):127-38. PubMed ID: 23852861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel HMGA2::KITLG fusion in a dedifferentiated liposarcoma with amplification of MDM2 and HMGA2.
    Zhou S; Zhang C; Zhang Z; Hu Y; Zhao L; Hu W; Chen S; Li B; Xiao S
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23200. PubMed ID: 37698344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
    Dantey K; Schoedel K; Yergiyev O; Bartlett D; Rao UNM
    Hum Pathol; 2017 Aug; 66():86-92. PubMed ID: 28300575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
    Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
    Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations.
    Tallini G; Dal Cin P; Rhoden KJ; Chiapetta G; Manfioletti G; Giancotti V; Fusco A; Van den Berghe H; Sciot R
    Am J Pathol; 1997 Jul; 151(1):37-43. PubMed ID: 9212729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the 12q13-15 amplicon in soft tissue tumors.
    Nilbert M; Rydholm A; Mitelman F; Meltzer PS; Mandahl N
    Cancer Genet Cytogenet; 1995 Aug; 83(1):32-6. PubMed ID: 7656201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors.
    Peng T; Zhang P; Liu J; Nguyen T; Bolshakov S; Belousov R; Young ED; Wang X; Brewer K; López-Terrada DH; Oliveira AM; Lazar AJ; Lev D
    Lab Invest; 2011 Mar; 91(3):392-403. PubMed ID: 21060307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HMGA2 and MDM2 expression in lipomatous tumors with partial, low-level amplification of sequences from the long arm of chromosome 12.
    Mandahl N; Bartuma H; Magnusson L; Isaksson M; Macchia G; Mertens F
    Cancer Genet; 2011 Oct; 204(10):550-6. PubMed ID: 22137485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors.
    Pedeutour F; Forus A; Coindre JM; Berner JM; Nicolo G; Michiels JF; Terrier P; Ranchere-Vince D; Collin F; Myklebost O; Turc-Carel C
    Genes Chromosomes Cancer; 1999 Jan; 24(1):30-41. PubMed ID: 9892106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line.
    Persson F; Olofsson A; Sjögren H; Chebbo N; Nilsson B; Stenman G; Aman P
    Cancer Lett; 2008 Feb; 260(1-2):37-47. PubMed ID: 18160213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.